“…Second, many studies have typically used measures developed and standardized for the general population (Young-Hyman & Davis, 2010), raising questions regarding their suitability and applicability to assess DEB or clinical threshold in individuals with type 1 diabetes. For example, general screening tools may overestimate problematic eating behaviors in people with type 1 diabetes when recommended diabetes management practices (e.g., restricting certain food groups, portion control) are misconstrued as DEB (Hanlan et al, 2013;Markowitz et al, 2010;Powers et al, 2013;Starkey & Wade, 2010;Young-Hyman & Davis, 2010). This may explain inconsistencies in prevalence data with some studies finding no significant differences in DEB or ED between young people with and without type 1 diabetes (Meltzer et al, 2001;Peveler, Fairburn, Boller, & Dunger, 1992;Striegel-Moore, Nicholson, & Tamborlane, 1992) and others finding evidence of an elevated risk (Colton et al, 2004;Jones, Lawson, Daneman, Olmsted, & Rodin, 2000;Neumark-Sztainer et al, 2002;Nielsen, 2002;Young et al, 2013).…”